• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume10, Issue2

Stability Indicating Reverse Phase High Performance Liquid Chromatography Method for Simultaneous Estimation of Allantoin, Hydroquinone and Tretenoin in Cream Formulation

    Rakesh Barik ,Somnath De,Durga Panikumar Anumolu,Sumeet Prachand,Veera Shakar Pulusu ,Satyabrata Jena .

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 2, Pages 1409-1418

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

In the current study, a reverse phase high performance liquid chromatography (RP-HPLC) approach that was developed and validated for the simultaneous quantification of hydroquinone, allantoin, and tretenoin in a cream formulation is discussed. On a reversed-phase InertsilC18 column (4.6 mm I.D. 250 mm, 5 m), the chromatographic separation was completed using a mobile phase made up of buffer (pH 3.5), 0.05 M potassium dihydrogen ortho phosphate-methanol (70:30% V/V), and UV detection at λmax 223nm. The technique demonstrated linearity, with Hydroquinone, Allantoin, and Tretenoin correlation coefficients of 0.999, 0.999, and 0.999 spanning ranges of 100-300 g/mL, 50 to 150 g/mL, and 0.625 to 1.875 g/mL, respectively. All of the components' mean recoveries ranged from 99.00 to 101.00%. The technique was approved in accordance with ICH standards. With no unwelcome interference, the established approach was extremely precise, repeatable, and detectable for hydroquinone, allantoin, and tretenoin together. The approach is effective in isolating the API from its degradants when judged on many criteria, including system suitability, precision, accuracy, linearity, robustness, and stability studies. It can be used to analyse samples of hydroquinone, allantoin, and tretenoin.
Keywords:
    Stability Indicating Reverse Phase High Performance Liquid Chromatography Method Simultaneous Estimation Allantoin Hydroquinone Tretenoin Cream Formulation
  • PDF (326 K)
  • XML
(2023). Stability Indicating Reverse Phase High Performance Liquid Chromatography Method for Simultaneous Estimation of Allantoin, Hydroquinone and Tretenoin in Cream Formulation. European Journal of Molecular & Clinical Medicine, 10(2), 1409-1418.
Rakesh Barik ,Somnath De,Durga Panikumar Anumolu,Sumeet Prachand,Veera Shakar Pulusu ,Satyabrata Jena .. "Stability Indicating Reverse Phase High Performance Liquid Chromatography Method for Simultaneous Estimation of Allantoin, Hydroquinone and Tretenoin in Cream Formulation". European Journal of Molecular & Clinical Medicine, 10, 2, 2023, 1409-1418.
(2023). 'Stability Indicating Reverse Phase High Performance Liquid Chromatography Method for Simultaneous Estimation of Allantoin, Hydroquinone and Tretenoin in Cream Formulation', European Journal of Molecular & Clinical Medicine, 10(2), pp. 1409-1418.
Stability Indicating Reverse Phase High Performance Liquid Chromatography Method for Simultaneous Estimation of Allantoin, Hydroquinone and Tretenoin in Cream Formulation. European Journal of Molecular & Clinical Medicine, 2023; 10(2): 1409-1418.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 23
  • PDF Download: 55
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus